Sian Bigora
Fondateur chez PROCESSA PHARMACEUTICALS, INC.
Fortune : 48 066 $ au 30/06/2024
Profil
Sian E.
Bigora is the founder of Processa Pharmaceuticals, Inc. and holds the title of Chief Development & Regulatory Officer since 2017.
Dr. Bigora is also the founder of Promet Therapeutics LLC.
Dr. Bigora's former job includes being the Vice President-Regulatory Affairs at Questcor Pharmaceuticals, Inc. from 2009 to 2015.
Dr. Bigora also worked as the Chief Risk Officer at GloboMax LLC and as a Pharmacokinetic Specialist at the University of Maryland School of Pharmacy.
Additionally, Dr. Bigora held the position of Vice President-Regulatory Affairs at ICON plc from 2005 to 2006 and VP-Clinical Research & Regulatory Affairs at AGI Therapeutics Plc from 2006 to 2009.
Dr. Bigora obtained a doctorate degree from the University of Maryland School of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/04/2024 | 21 458 ( 0,75% ) | 48 066 $ | 30/06/2024 |
Postes actifs de Sian Bigora
| Sociétés | Poste | Début |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Fondateur | 29/03/2011 |
Anciens postes connus de Sian Bigora
| Sociétés | Poste | Fin |
|---|---|---|
| QUESTCOR PHARMACEUTICALS INC | Conseiller Juridique Général | 01/01/2015 |
AGI Therapeutics Plc
 AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Directeur Technique/Scientifique/R&D | 01/11/2009 |
| ICON PUBLIC LIMITED COMPANY | Conseiller Juridique Général | 01/01/2006 |
| GloboMax LLC | Corporate Officer/Principal | - |
Promet Therapeutics LLC
 Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Fondateur | - |
Formation de Sian Bigora
| University of Maryland School of Pharmacy | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Entreprise privées | 4 |
|---|---|
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |
| GloboMax LLC |
